... in the stem cell biotechnology sector based on the intellectual property of Dr. Samuel Weiss in stem cell research. SCT proposes to build upon the foundational technologies by acquiring additional early-stage clinical or late-stage preclinical ...
http://www.marketwire.com/press-release/stem-cell-therapeutics-announces-shareholder-approval-share-consolidation-proposal-tsx-venture-sss-1740405.htm
http://www.marketwire.com/press-release/stem-cell-therapeutics-announces-shareholder-approval-share-consolidation-proposal-tsx-venture-sss-1740405.htm
No comments:
Post a Comment